Science Explorer Back to mapMap
Discussion
Company · Irving · United States

Caris Life Sciences (United States)

In research, Caris Life Sciences (United States) stands highest in Health Sciences (#5,936 of 9,902 worldwide) and Medicine (#5,928 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Biochemistry, Genetics and Molecular Biology (Oncology is 18.8× its share of world research).

carislifesciences.comROR OpenAlex
World rank, 2022-now
#20,520
of 22,385 · #25,396 all time
Rank in United States
#3,037
of 3,332
Research works
422
▲ 95% vs 2018-21
Citations
5.8k
13.6 per fractional work
Top-10% rate
14.4%
all institutions 10.0%
vs its own fields
0.96×
1.00× is exactly expected
Open access
31%
world 40%
International
17%
world 18%
Caris Life Sciences (United States)

What is Caris Life Sciences (United States) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #5,936 of 9,902 17.7%82 #7032
MedicineField #5,928 of 8,541 17.5%81 #6788

Each strip is that field's whole ranked pool, with the notch where Caris Life Sciences (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Caris Life Sciences (United States) work in?

In 2022-now, 64% of research at Caris Life Sciences (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (3%). It does 2.6× the world's share of Health Sciences.

Health Sciences: 101 fractional works · 63.6% of its workMedicine: 100 fractional works · 63.0% of its workOncology: 34 fractional works · 21.2% of its workPulmonary and Respiratory Medicine: 25 fractional works · 15.8% of its workSurgery: 6 fractional works · 4.1% of its workRadiology, Nuclear Medicine and Imaging: 6 fractional works · 3.9% of its workPathology and Forensic Medicine: 5 fractional works · 3.4% of its workGenetics: 3 fractional works · 2.1% of its workEpidemiology: 3 fractional works · 2.0% of its workReproductive Medicine: 3 fractional works · 1.7% of its workObstetrics and Gynecology: 2 fractional works · 1.3% of its workNeurology: 2 fractional works · 1.1% of its workRheumatology: 1 fractional works · 0.8% of its workOtorhinolaryngology: 1 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workHematology: 1 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.4% of its workHepatology: 1 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workPharmacology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 54 fractional works · 33.9% of its workBiochemistry, Genetics and Molecular Biology: 48 fractional works · 30.5% of its workMolecular Biology: 25 fractional works · 15.7% of its workCancer Research: 18 fractional works · 11.1% of its workGenetics: 4 fractional works · 2.7% of its workCell Biology: 1 fractional works · 0.5% of its workBiotechnology: 1 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 2.5% of its workImmunology: 4 fractional works · 2.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 0.4% of its workPlant Science: 1 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 1.7% of its workComputer Science: 2 fractional works · 1.0% of its workArtificial Intelligence: 1 fractional works · 0.7% of its workInformation Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemical Engineering: 0 fractional works · 0.2% of its workChemical Health and Safety: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.0% of its workPhysics and Astronomy: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.2% of its workConservation: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workALL ITS WORKCaris LifeSciences (United…158fractional works, 2022-now
Life Sciences34%Physical Sciences2%Health Sciences64%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine10063.0%
    2. Dentistry00.3%
    3. Nursing00.2%
    4. Veterinary00.1%
    5. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology4830.5%
    2. Immunology and Microbiology42.5%
    3. Agricultural and Biological Sciences10.4%
    4. Pharmacology, Toxicology and Pharmaceutics00.2%
    5. Neuroscience00.2%
    1. Computer Science21.0%
    2. Chemical Engineering00.2%
    3. Environmental Science00.2%
    4. Engineering00.1%
    5. Chemistry00.1%
    6. Mathematics00.0%
    7. Physics and Astronomy00.0%
    1. Psychology00.2%
    2. Arts and Humanities00.2%
    3. Social Sciences00.2%
    4. Economics, Econometrics and Finance00.2%
    5. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Caris Life Sciences (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 18.8× the share of its output that it takes of world research.

  1. OncologySubfield · 33.5 works19×
  2. Pulmonary and Respiratory MedicineSubfield · 25.0 works10×
  3. Biochemistry, Genetics and Molecular BiologyField · 48.4 works5.7×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.73× its world share, 48 worksBiochemistry, Geneti…Immunology and Microbiology: 2.52× its world share, 4 worksImmunology and Micro…Neuroscience: 0.09× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.56× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.60× its world share, 0 worksChemical EngineeringChemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.13× its world share, 2 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMathematics: 0.04× its world share, 0 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyDentistry: 0.57× its world share, 0 worksDentistryHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 3.27× its world share, 100 worksMedicineNursing: 0.46× its world share, 0 worksNursingVeterinary: 0.52× its world share, 0 worksVeterinaryArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.08× its world share, 0 worksEconomics, Econometr…Psychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.7×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.73×48 works
  2. Medicine3.27×100 works
  3. Immunology and Microbiology2.52×4 works
  4. Chemical Engineering0.60×0 works
  5. Dentistry0.57×0 works
  6. Pharmacology, Toxicology and Pharmaceutics0.56×0 works
  7. Veterinary0.52×0 works
  8. Nursing0.46×0 works
  9. Computer Science0.13×2 works
  10. Agricultural and Biological Sciences0.09×1 works
  11. Neuroscience0.09×0 works
  12. Chemistry0.08×0 works
  13. Economics, Econometrics and Finance0.08×0 works
  14. Psychology0.08×0 works
  15. Arts and Humanities0.07×0 works
  16. Mathematics0.04×0 works
  17. Environmental Science0.03×0 works
  18. Health Professions0.02×0 works
  19. Social Sciences0.02×0 works
  20. Engineering0.01×0 works
  21. Physics and Astronomy0.01×0 works
  22. Business, Management and Accounting0.01×0 works

Who are the top researchers at Caris Life Sciences (United States)?

Ranked on the quality score, Matthew James Oberley, David B. Spetzler and Jim P. Abraham lead among researchers whose main affiliation is Caris Life Sciences (United States).

  1. 1 Matthew James Oberley United States · #134,749 worldwide 3.5k citations · 377 works
  2. 2 David B. Spetzler United States · #145,874 worldwide 10k citations · 340 works
  3. 3 Jim P. Abraham United States · #146,756 worldwide 679 citations · 100 works
  4. 4 Jeffrey J. Swensen United States · #190,395 worldwide 13k citations · 219 works
  5. 5 Wolfgang Michael Korn United States · #237,962 worldwide 9.4k citations · 630 works
  6. 6 Ari M. Vanderwalde United States · #292,368 worldwide 8.6k citations · 530 works
  7. 7 Andrew Elliott United States · #301,274 worldwide 1.4k citations · 607 works
  8. 8 Sachin Kumar Deshmukh United States · #310,183 worldwide 1.8k citations · 101 works
  9. 9 Sherri Z. Millis United States · #342,550 worldwide 12k citations · 160 works
  10. 10 Kelsey Anne Poorman United States · #353,345 worldwide 974 citations · 77 works
All ranked researchers at Caris Life Sciences (United States)

What are the most cited papers from Caris Life Sciences (United States)?

The most cited paper from Caris Life Sciences (United States) is "Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade" (Dung Thi Le et al., 2017), with 6,813 citations. Next come "Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function" (1,679) and "Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study" (1,110).

Most cited papers
#PaperReleasedCitations
1 Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Dung Thi Le et al. · Science Open access 27 Jul 2017 6,813
2 Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function Torsten Olszak, Dingding An, Sebastian Zeißig et al. · Science Open access 23 Mar 2012 1,679
3 Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al. · The Lancet Mar 2011 1,110
4 Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal Ino de Bruijn et al. · Cancer Research Open access 5 Sep 2023 918
5 Changes in circulating microRNA levels associated with prostate cancer Richard J. Bryant, Traci L. Pawlowski, James W.F. Catto et al. · British Journal of Cancer Open access 12 Jan 2012 719
All 60 most cited papers, with filters and sorting

Which keywords describe research at Caris Life Sciences (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Immunotherapy, Cancer, Tumor Microenvironment, Clinical Trials, Breast Cancer and Genomic Instability.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy22▲ 20×19 topics
  2. Targeted Therapy21▲ 59×5 topics
  3. Immunotherapy20▲ 17×17 topics
  4. Cancer18▲ 8.4×32 topics
  5. Tumor Microenvironment16▲ 23×7 topics
  6. Clinical Trials15▲ 15×6 topics
  7. Breast Cancer12▲ 30×9 topics
  8. Genomic Instability12▲ 67×2 topics
  9. Cell-Free DNA11▲ 74×2 topics
  10. Cancer Genomics11▲ 99×1 topic
  11. Mutational Signatures11▲ 99×1 topic
  12. Biomarkers11▲ 9.6×9 topics
  13. Genomic Profiling10▲ 58×2 topics
  14. Prognostic Factors10▲ 14×13 topics
  15. Metastasis9▲ 17×9 topics
  16. Cancer Therapy9▲ 10×13 topics
  17. Gene Expression9▲ 8.6×12 topics
  18. Precision Medicine8▲ 10×6 topics
  19. Genetic Mutations8▲ 11×12 topics
  20. Immune Checkpoint Blockade7▲ 40×1 topic
  21. PD-1 and PD-L17▲ 40×1 topic
  22. Radiotherapy7▲ 12×9 topics
  23. Survival Analysis7▲ 16×6 topics
  24. Clinical Practice Guidelines6▲ 7.5×8 topics
  25. Neoadjuvant Therapy6▲ 17×5 topics
  26. Molecular Subtypes6▲ 45×3 topics
  27. Treatment Guidelines6▲ 18×2 topics
  28. ALK Inhibitors6▲ 60×1 topic
  29. Cell Death6▲ 15×5 topics
  30. EGFR Mutations6▲ 60×1 topic
  31. Molecular Characterization6▲ 21×4 topics
  32. Metastatic Breast Cancer5▲ 55×2 topics
  33. Monoclonal Antibody5▲ 58×2 topics
  34. Metastatic5▲ 48×2 topics
  35. Cetuximab5▲ 37×2 topics
  36. Molecular Classification5▲ 20×4 topics
  37. Genomic Analysis5▲ 11×5 topics
  38. Cell Cycle Control4▲ 84×2 topics
  39. CDK4/6 Inhibitors4▲ 97×1 topic
  40. Prostate Cancer4▲ 21×4 topics

Which research topics does Caris Life Sciences (United States) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Advanced Breast Cancer Therapies.

Cancer Genomics and Diag…11Cancer Genomics and Diagnostics: 11 fractional worksCancer Immunotherapy and Biomarkers: 7 fractional worksLung Cancer Treatments a…6Lung Cancer Treatments and Mutations: 6 fractional worksAdvanced Breast Cancer T…4Advanced Breast Cancer Therapies: 4 fractional worksHER2/EGFR in Cancer Research: 4 fractional worksColorectal Cancer Treatments and Studies: 4 fractional worksProstate Cancer Treatmen…4Prostate Cancer Treatment and Research: 4 fractional worksFerroptosis and cancer prognosis: 3 fractional worksLung Cancer Research Studies: 3 fractional worksGenetic factors in colorectal cancer: 3 fractional works
Cancer ResearchOncologyPulmonary and Respiratory MedicinePathology and Forensic Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 11 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 7 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
  5. 5 HER2/EGFR in Cancer Research Oncology 4 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 4 works
  7. 7 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 4 works
  8. 8 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 3 works
  9. 9 Lung Cancer Research Studies Oncology 3 works
  10. 10 Genetic factors in colorectal cancer Pathology and Forensic Medicine 3 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.4%not open68.6%

World: 40% of research is openly available.

with international co-authors17.2%domestic only82.8%

World: 18% is written across borders.

How has Caris Life Sciences (United States)'s research output changed?

Output in 2022-2025 was 95% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Caris Life Sciences (United States) as a percentage of every work published that year, 0.00069% in 2024.

still counting0.00050%0.0010%0.0015%Caris Life Sciences (United States)0.00081% in 202519801990200020102020

Fractional works of Caris Life Sciences (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting20%40%Caris Life Sciences (United States)18.3% in 2025all institutions10.0% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 30.6% in 2012.

Other research institutions in Irving

All research institutions in Irving

Share Caris Life Sciences (United States)'s ranking

Caris Life Sciences (United States) on Science Explorer

A card with Caris Life Sciences (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Caris Life Sciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.